ID RERF-LC-OK AC CVCL_3154 SY RERF-LCOK; RERFLCOK; LC-OK; LCOK; Radiation Effects Research Foundation-Lung Cancer-OK DR EFO; EFO_0006744 DR ArrayExpress; E-MTAB-2706 DR BioSample; SAMN03151836 DR BioSample; SAMN03471743 DR cancercelllines; CVCL_3154 DR Cell_Model_Passport; SIDM00385 DR CGH-DB; 207-1 DR CGH-DB; 9167-4 DR Cosmic; 753609 DR Cosmic; 801580 DR Cosmic; 876139 DR Cosmic; 889096 DR Cosmic; 917974 DR Cosmic; 932927 DR Cosmic; 934469 DR Cosmic; 946065 DR Cosmic; 1066168 DR Cosmic; 1219088 DR Cosmic; 1239899 DR Cosmic; 1571720 DR Cosmic; 2125286 DR Cosmic; 2668321 DR EGA; EGAS00001000610 DR GEO; GSM274667 DR IARC_TP53; 11873 DR IARC_TP53; 28443 DR JCRB; JCRB0811 DR PharmacoDB; RERFLCOK_1307_2019 DR Wikidata; Q54949775 RX PubMed=7834619; RX PubMed=9290701; RX PubMed=10536175; RX PubMed=11005564; RX PubMed=14581340; RX PubMed=15185009; RX PubMed=15746151; RX PubMed=16105816; RX PubMed=19472407; RX PubMed=20143388; RX PubMed=20557307; RX PubMed=25485619; RX PubMed=25877200; RX PubMed=26589293; WW Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx WW Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm CC Problematic cell line: Contaminated. Shown to be a Marcus derivative (PubMed=20143388). Originally thought to originate from a lung adenocarcinoma. CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00344. CC Population: Caucasian. CC HLA typing: A*03:02,24:02; B*08:01,35:08; C*03:03,07:01; DRB1*04:22,04:22 (PubMed=26589293). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Cys (c.338T>G); ClinVar=VCV000634690; Zygosity=Unspecified (PubMed=10536175; PubMed=20557307). CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Misspelling: PERF-LC-OK; Cosmic=2125286. CC Misspelling: REAF-LC-OK; Cosmic=1571720. CC Misspelling: RERF-LOCK; IARC_TP53=11873; PubMed=10536175. CC Discontinued: JCRB; JCRB0811; true. ST Source(s): JCRB=JCRB0811; PubMed=25877200 ST Amelogenin: X ST CSF1PO: 12,15 ST D13S317: 11 ST D16S539: 12,13 ST D18S51: 15 ST D21S11: 29 ST D3S1358: 15,16 ST D5S818: 11,12 ST D7S820: 9,11 ST D8S1179: 13,14 ST FGA: 20 ST Penta D: 15 ST Penta E: 12,20 ST TH01: 9,9.3 ST TPOX: 8,11 ST vWA: 17 DI NCIt; C60781; Astrocytoma DI ORDO; Orphanet_94; Astrocytoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_3019 ! Marcus SX Female AG 59Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 34 // RX PubMed=19472407; DOI=10.1002/humu.21028; PMCID=PMC2900846; RA Blanco, Raquel RA Iwakawa, Reika RA Tang, Mo-Ying RA Kohno, Takashi RA Angulo, Barbara RA Pio, Ruben RA Montuenga, Luis M. RA Minna, John D. RA Yokota, Jun RA Sanchez-Cespedes, Montse RT "A gene-alteration profile of human lung cancer cell lines."; RL Hum. Mutat. 30:1199-1206(2009). // RX PubMed=14581340; RA Yokoi, Sana RA Yasui, Kohichiroh RA Iizasa, Toshihiko RA Imoto, Issei RA Fujisawa, Takehiko RA Inazawa, Johji RT "TERC identified as a probable target within the 3q26 amplicon that is RT detected frequently in non-small cell lung cancers."; RL Clin. Cancer Res. 9:4705-4713(2003). // RX PubMed=20557307; DOI=10.1111/j.1349-7006.2010.01622.x; PMCID=PMC11158680; RA Iwakawa, Reika RA Kohno, Takashi RA Enari, Masatoshi RA Kiyono, Tohru RA Yokota, Jun RT "Prevalence of human papillomavirus 16/18/33 infection and p53 RT mutation in lung adenocarcinoma."; RL Cancer Sci. 101:1891-1896(2010). // RX PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D; RA Jia, Li-Qun RA Osada, Motonobu RA Ishioka, Chikashi RA Gamo, Makio RA Ikawa, Shuntaro RA Suzuki, Takao RA Shimodaira, Hideki RA Niitani, Tomohito RA Kudo, Toshio RA Akiyama, Mitoshi RA Kimura, Narimiti RA Matsuo, Mitsuyoshi RA Mizusawa, Hiroshi RA Tanaka, Noriho RA Koyama, Hideki RA Namba, Masayoshi RA Kanamaru, Ryunosuke RA Kuroki, Toshio RT "Screening the p53 status of human cell lines using a yeast functional RT assay."; RL Mol. Carcinog. 19:243-253(1997). // RX PubMed=25485619; DOI=10.1038/nbt.3080; RA Klijn, Christiaan RA Durinck, Steffen RA Stawiski, Eric W. RA Haverty, Peter M. RA Jiang, Zhao-Shi RA Liu, Han-Bin RA Degenhardt, Jeremiah RA Mayba, Oleg RA Gnad, Florian RA Liu, Jin-Feng RA Pau, Gregoire RA Reeder, Jens RA Cao, Yi RA Mukhyala, Kiran RA Selvaraj, Suresh K. RA Yu, Ma-Mie RA Zynda, Gregory J. RA Brauer, Matthew J. RA Wu, Thomas D. RA Gentleman, Robert Clifford RA Manning, Gerard RA Yauch, Robert L. RA Bourgon, Richard RA Stokoe, David RA Modrusan, Zora RA Neve, Richard M. RA de Sauvage, Frederic J. RA Settleman, Jeffrey RA Seshagiri, Somasekar RA Zhang, Ze-Min RT "A comprehensive transcriptional portrait of human cancer cell RT lines."; RL Nat. Biotechnol. 33:306-312(2015). // RX PubMed=25877200; DOI=10.1038/nature14397; RA Yu, Ma-Mie RA Selvaraj, Suresh K. RA Liang-Chu, May M.Y. RA Aghajani, Sahar RA Busse, Matthew RA Yuan, Jean RA Lee, Genee RA Peale, Franklin V. RA Klijn, Christiaan RA Bourgon, Richard RA Kaminker, Joshua S. RA Neve, Richard M. RT "A resource for cell line authentication, annotation and quality RT control."; RL Nature 520:307-311(2015). // RX PubMed=16105816; DOI=10.1158/0008-5472.CAN-05-0331; RA Nagai, Yoshiaki RA Miyazawa, Hitoshi RA No_last_name, Huqun RA Tanaka, Tomoaki RA Udagawa, Kiyoshi RA Kato, Motoyasu RA Fukuyama, Shunichiro RA Yokote, Akemi RA Kobayashi, Kunihiko RA Kanazawa, Minoru RA Hagiwara, Koichi RT "Genetic heterogeneity of the epidermal growth factor receptor in RT non-small cell lung cancer cell lines revealed by a rapid and RT sensitive detection system, the peptide nucleic acid-locked nucleic RT acid PCR clamp."; RL Cancer Res. 65:7276-7282(2005). // RX PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878; RA Scholtalbers, Jelle RA Boegel, Sebastian RA Bukur, Thomas RA Byl, Marius RA Goerges, Sebastian RA Sorn, Patrick RA Loewer, Martin RA Sahin, Ugur RA Castle, John C. RT "TCLP: an online cancer cell line catalogue integrating HLA type, RT predicted neo-epitopes, virus and gene expression."; RL Genome Med. 7:118.1-118.7(2015). // RX PubMed=20143388; DOI=10.1002/ijc.25242; RA Capes-Davis, Amanda RA Theodosopoulos, George RA Atkin, Isobel RA Drexler, Hans Gunther RA Kohara, Arihiro RA MacLeod, Roderick A.F. RA Masters, John R.W. RA Nakamura, Yukio RA Reid, Yvonne A. RA Reddel, Roger Robert RA Freshney, Robert Ian RT "Check your cultures! A list of cross-contaminated or misidentified RT cell lines."; RL Int. J. Cancer 127:1-8(2010). // RX PubMed=15185009; DOI=10.1007/s00262-004-0533-9; PMCID=PMC11034254; RA Yamaji, Haruko RA Iizasa, Toshihiko RA Koh, Eitetsu RA Suzuki, Makoto RA Otsuji, Mizuto RA Chang, Hao RA Motohashi, Shinichiro RA Yokoi, Sana RA Hiroshima, Kenzo RA Tagawa, Masatoshi RA Nakayama, Toshinori RA Fujisawa, Takehiko RT "Correlation between interleukin 6 production and tumor proliferation RT in non-small cell lung cancer."; RL Cancer Immunol. Immunother. 53:786-792(2004). // RX PubMed=11005564; DOI=10.1038/sj.neo.7900094; PMCID=PMC1550293; RA Kohno, Takashi RA Sato, Takako RA Takakura, Satoshi RA Takei, Kimiko RA Inoue, Kaoru RA Nishioka, Michiho RA Yokota, Jun RT "Mutation and expression of the DCC gene in human lung cancer."; RL Neoplasia 2:300-305(2000). // RX PubMed=10536175; DOI=10.3892/ijo.15.5.927; RA Fujita, Takeshi RA Kiyama, Masaharu RA Tomizawa, Yoshio RA Kohno, Takashi RA Yokota, Jun RT "Comprehensive analysis of p53 gene mutation characteristics in lung RT carcinoma with special reference to histological subtypes."; RL Int. J. Oncol. 15:927-934(1999). // RX PubMed=15746151; DOI=10.1093/hmg/ddi092; RA Izumi, Hiroto RA Inoue, Jun RA Yokoi, Sana RA Hosoda, Hiroshi RA Shibata, Tatsuhiro RA Sunamori, Makoto RA Hirohashi, Setsuo RA Inazawa, Johji RA Imoto, Issei RT "Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in RT non-small cell lung cancers."; RL Hum. Mol. Genet. 14:997-1007(2005). // RX PubMed=7834619; RA Washimi, Osuke RA Nagatake, Masaaki RA Osada, Hirotaka RA Ueda, Ryuzo RA Koshikawa, Takashi RA Seki, Tsuneo RA Takahashi, Toshitada RA Takahashi, Takashi RT "In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations RT preferentially in non-small cell lung cancers."; RL Cancer Res. 55:514-517(1995). //